Dr Meena Mehta, MD | |
131 Ornac, Suite 610, Concord, MA 01742-4181 | |
(978) 371-7778 | |
(978) 369-9514 |
Full Name | Dr Meena Mehta |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 42 Years |
Location | 131 Ornac, Concord, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285615310 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 78055 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Melrosewakefield Healthcare | Melrose, MA | Hospital |
Emerson Hospital - | W concord, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Krishma Medical Associates Pc | 7719966944 | 2 |
Ognomy Sleep Associates Nj Llc | 5597120543 | 5 |
Ognomy Sleep Associates Nj Llc | 5597120543 | 5 |
News Archive
People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing an allergic reaction to the very treatment that can prolong their lives.
Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that the combination of immunotherapy and chemotherapy significantly slowed tumor progression and extended survival of patients with glioblastoma multiforme (GBM).
Critics of the fluoride-IQ study published this month in JAMA Pediatrics claimed it needed replication. However, the Canadian study by Green (2019) was already a replication of another U.S. government-funded study published in 2017 by Bashash which found similar effects, reports the Fluoride Action Network.
The use of simulation techniques in medical education, such as lifelike mannequins and computer systems, results in improved patient care, better outcomes and other benefits, according to a study led by a Loyola University Chicago Stritch School of Medicine researcher.
› Verified 3 days ago
Entity Name | Krishma Medical Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922115559 PECOS PAC ID: 7719966944 Enrollment ID: O20050321000102 |
News Archive
People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing an allergic reaction to the very treatment that can prolong their lives.
Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that the combination of immunotherapy and chemotherapy significantly slowed tumor progression and extended survival of patients with glioblastoma multiforme (GBM).
Critics of the fluoride-IQ study published this month in JAMA Pediatrics claimed it needed replication. However, the Canadian study by Green (2019) was already a replication of another U.S. government-funded study published in 2017 by Bashash which found similar effects, reports the Fluoride Action Network.
The use of simulation techniques in medical education, such as lifelike mannequins and computer systems, results in improved patient care, better outcomes and other benefits, according to a study led by a Loyola University Chicago Stritch School of Medicine researcher.
› Verified 3 days ago
Entity Name | Ognomy Sleep Associates Nj Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1407566094 PECOS PAC ID: 5597120543 Enrollment ID: O20230607001536 |
News Archive
People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing an allergic reaction to the very treatment that can prolong their lives.
Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that the combination of immunotherapy and chemotherapy significantly slowed tumor progression and extended survival of patients with glioblastoma multiforme (GBM).
Critics of the fluoride-IQ study published this month in JAMA Pediatrics claimed it needed replication. However, the Canadian study by Green (2019) was already a replication of another U.S. government-funded study published in 2017 by Bashash which found similar effects, reports the Fluoride Action Network.
The use of simulation techniques in medical education, such as lifelike mannequins and computer systems, results in improved patient care, better outcomes and other benefits, according to a study led by a Loyola University Chicago Stritch School of Medicine researcher.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Meena Mehta, MD 131 Ornac, Suite 610, Concord, MA 01742-4181 Ph: (978) 371-7778 | Dr Meena Mehta, MD 131 Ornac, Suite 610, Concord, MA 01742-4181 Ph: (978) 371-7778 |
News Archive
People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing an allergic reaction to the very treatment that can prolong their lives.
Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that the combination of immunotherapy and chemotherapy significantly slowed tumor progression and extended survival of patients with glioblastoma multiforme (GBM).
Critics of the fluoride-IQ study published this month in JAMA Pediatrics claimed it needed replication. However, the Canadian study by Green (2019) was already a replication of another U.S. government-funded study published in 2017 by Bashash which found similar effects, reports the Fluoride Action Network.
The use of simulation techniques in medical education, such as lifelike mannequins and computer systems, results in improved patient care, better outcomes and other benefits, according to a study led by a Loyola University Chicago Stritch School of Medicine researcher.
› Verified 3 days ago
Dr. William Judson Burtis, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 747 Main St, Suite 123, Concord, MA 01742 Phone: 978-287-9590 Fax: 978-287-5700 | |
C Gregory Martin, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 133 Ornac, Concord, MA 01742 Phone: 978-287-3111 Fax: 978-287-3675 | |
Dr. Paul David D'ambrosio, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2284 Main St, Concord, MA 01742 Phone: 978-369-5575 Fax: 978-371-9189 | |
Richard P Schwartz, MD PC Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac Ste 510, John Cuming Building, Concord, MA 01742 Phone: 978-776-6186 Fax: 978-776-6189 | |
Thomas Lamattina, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac, Concord, MA 01742 Phone: 978-371-0796 | |
Dr. Peter Scott Benjamin, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 133 Ornac, Concord, MA 01742 Phone: 978-287-3627 | |
Stephen M Dyda, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 131 Ornac, Concord, MA 01742 Phone: 978-287-8767 |